TRANSACTIONS
Recent Selected Transactions
2021 : Novadip 21M€ series B1 financing
2021 : Robocath secures 15M€ financing with EIB
2020 : Robocath 40M€ series C financing
2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals
2019 : Beaver Visitec acquires Arcadophta
2019 : FineHeart 5M€ bridge financing
2019 : Senior Assist 20M€ growth financing
2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada
2018 : Licensing-out Advisory for Acteon
2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US
2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals
2016 : M&A Buy Side Advisory for Vifor Pharmaceuticals in European specialty pharma transaction
2016 : Licensing-out Advisory for Intsel Chimos
Bionest Partners Finance has performed an extensive number of Financial Advisory projects for Healthtech startups and specialty Pharma companies (fairness opinion, business plan, deal structuring).